tiprankstipranks
Trending News
More News >
Shield Therapeutics (GB:STX)
:STX
UK Market

Shield Therapeutics (STX) Cash flow

Compare
22 Followers

Shield Therapeutics Cash Flow

GB:STX's free cash flow for Q4 2024 was £-3.66M. For the 2024 fiscal year, GB:STX's free cash flow was decreased by £33.04M and operating cash flow was £-3.66M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
£ -7.01M£ -37.13M£ -18.25M£ -16.74M£ -1.40M
Investing Cash Flow
£ -1.89M£ -2.43M£ -1.70M£ -2.05M£ -20.00K
Financing Cash Flow
£ 4.21M£ 49.66M£ 7.71M£ 27.58M£ -47.00K
End Cash Position
£ 5.61M£ 13.95M£ 2.82M£ 12.12M£ 2.94M
Free Cash Flow
£ -7.03M£ -40.07M£ -20.14M£ -18.80M£ -1.42M
Currency in GBP

Shield Therapeutics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis